Indian pharma major Sun Pharma (BSE: 524715) reported positive top-line results from two late-stage studies of its psoriasis ...

Pittsburgh, USA-based Viatris, which was formed in 2020 through the merger of Mylan and Pfizer's, saw its shares fall 4.2% to ...

The Psychopharmacologic Drugs Advisory Committee (PDAC) of the US Food and Drug Administration (FDA) met to discuss the supplemental New Drug Application (sNDA) of Rexulti (brexpiprazole) in ...

The Dutch Ministry of Economic Affairs (EZ) has presented an ambitious action plan to increase public and private investment ...

Research news of note last week included US biotech Crinetics Pharmaceuticals releasing new Phase III data on its acromegaly drug candidate Palsonify (paltusotine). AstraZeneca announced positive ...

As of July 18, 2025, the Food and Drug Administration (FDA) said it has received three reports of fatal acute liver failure ...

The European Commission granted conditional marketing authorization for Ezmekly (mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients ...

US pharma major Bristol Myers Squibb’s shares remained steady, despite the company reporting disappointing results from its ...

Danish allergy immunotherapy specialist ALK Abello has announced that the UK’s Medicines and Healthcare Products Regulatory ...

Oncologic Drugs Advisory Committee has voted against two proposed combination regimens containing GSK’s Blenrep (belantamab ...

In what is not exactly a win-win situation for the Indian generic firms, a recent federal court ruling in Delaware, USA, has ...

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...